Seres Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Seres Therapeutics Inc
CIK #0001609809
EDGAR Form CIK 2011 - 2026
10-K [0001609809]
10-Q [0001609809]
3 [0001609809]
4 [0001609809]
8-K [0001609809]
D [0001609809]
SC 13D [0001609809]
SC 13G [0001609809]
Form 13D/13G Filer Form 13D/13G Subject Filed
BlackRock Inc Seres Therapeutics Inc [2024-01-29]
BlackRock Inc Seres Therapeutics Inc [2023-02-03]
Federated Hermes Inc Seres Therapeutics Inc [2022-02-14]
Janus Henderson Group PLC Seres Therapeutics Inc [2022-02-11]
Vanguard Group Inc Seres Therapeutics Inc [2022-02-10]
State Street Corp Seres Therapeutics Inc [2021-10-12]
RA Capital Management LP Seres Therapeutics Inc [2021-05-05]
BlackRock Inc Seres Therapeutics Inc [2020-02-07]
Sumitomo Mitsui Trust Holdings Inc Seres Therapeutics Inc [2019-09-09]
Nikko Asset Management Americas Inc Seres Therapeutics Inc [2019-09-06]
Flagship Venturelabs IV LLC Seres Therapeutics Inc [2019-06-28]
Ark Investment Management LLC Seres Therapeutics Inc [2019-02-14]
BlackRock Inc Seres Therapeutics Inc [2019-02-08]
Nestle Health Science US Holdings Inc Seres Therapeutics Inc [2018-04-11]
Flagship Ventures Fund 2007 LP Seres Therapeutics Inc [2016-02-16]
FMR LLC Seres Therapeutics Inc [2015-09-10]
Nestle Health Science US Holdings Inc Seres Therapeutics Inc [2015-07-06]
Form 3/4/5 Subject 2011 - 2026
Seres Therapeutics Inc
Ausiello Dennis A
Berenson Stephen
Rosiello Robert L
Henn Matthew R
Shaff Eric D
Brady Kelly
DesRosier Thomas
Thorell Marella
Kender Richard N
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Seres Therapeutics Inc MCRB
Stock Option (right to buy) · derivative
2026-03-04 Grant 150,000 $0.00
Seres Therapeutics Inc MCRB
Stock Option (right to buy) · derivative
2026-03-04 Grant 22,500 $0.00
Seres Therapeutics Inc MCRB
Stock Option (right to buy) · derivative
2026-03-04 Grant 56,250 $0.00
Seres Therapeutics Inc MCRB
Stock Option (right to buy) · derivative
2026-03-04 Grant 75,000 $0.00
Seres Therapeutics Inc MCRB
Stock Option (right to buy) · derivative
2026-03-04 Grant 22,500 $0.00
Seres Therapeutics Inc MCRB
Common Stock
2026-02-15 Option exercise 723
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
2026-02-15 Option exercise 141 $0.00
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
2026-02-15 Option exercise 391 $0.00
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
2026-02-15 Option exercise 98 $0.00
Seres Therapeutics Inc MCRB
Common Stock
2026-02-15 Option exercise 231
Seres Therapeutics Inc MCRB
Common Stock
2026-02-15 Sell 78 $8.47 661
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
2026-02-15 Option exercise 111 $0.00
Seres Therapeutics Inc MCRB
Common Stock
2026-02-15 Sell 259 $8.47 2,194
Seres Therapeutics Inc MCRB
Common Stock
2026-02-15 Option exercise 244
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
2026-02-15 Option exercise 133 $0.00
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
2026-02-15 Option exercise 98 $0.00
Seres Therapeutics Inc MCRB
Common Stock
2026-02-15 Sell 75 $8.47 635
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
2026-02-15 Option exercise 333 $0.00
Seres Therapeutics Inc MCRB
Common Stock
2026-02-15 Sell 89 $8.47 754
Seres Therapeutics Inc MCRB
Restricted Stock Units · derivative
2026-02-15 Option exercise 133 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com